Fox Jennifer Lynne
SEC CIK 1914879 · EDGAR
Most active insiders at MYGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Phanstiel S. Louise | Dir | $494.5K | — |
| 2 | Raha Samraat S. | Pres, CEO, Dir | $200.0K | — |
| 3 | Kumar Rashmi | Dir | — | $66.8K |
| 4 | Bisaro Paul | Dir | $27.6K | — |
| 5 | Jampa Raj | CTO | — | — |
| 6 | Wheeler Benjamin Richard | CFO | — | — |
| 7 | Donnelly Brian J | Chief Commerical Off | — | — |
| 8 | Davis Mark Steven | Dir | — | — |
| 9 | Sikri Vishal | EVP, Commercial | — | — |
| 10 | Muzzey Dale | CSO | — | — |
| 11 | Fox Jennifer Lynne | CLO | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 16:18 | 2026-09-03 | MYGN | MYRIAD GENETICS INC | Fox Jennifer Lynne | CLO | F - Tax | $3.23 | -4,398 | 306.0K | -1% | -$14.2K | |
| 2026-03-16 | 2026-03-12 | MYGN | MYRIAD GENETICS INC | Fox Jennifer Lynne | CLO | A - Grant | $0.00 | +195.9K | 316.4K | +163% | $0 | |
| 2026-03-16 | 2026-03-13 | MYGN | MYRIAD GENETICS INC | Fox Jennifer Lynne | CLO | F - Tax | $4.66 | -5,995 | 310.4K | -2% | -$27.9K | |
| 2025-09-04 | 2025-09-03 | MYGN | MYRIAD GENETICS INC | Fox Jennifer Lynne | CLO | F - Tax | $6.80 | -4,435 | 120.5K | -4% | -$30.2K | |
| 2025-03-17 | 2025-03-13 | MYGN | MYRIAD GENETICS INC | Fox Jennifer Lynne | CLO | A - Grant | $0.00 | +63.1K | 124.9K | +102% | $0 | |
| 2024-09-04 | 2024-09-03 | MYGN | MYRIAD GENETICS INC | Fox Jennifer Lynne | CLO | A - Grant | $0.00 | +61.8K | 61.8K | New | $0 | |
| 2024-07-12 | 2024-07-11 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | A - Grant | $0.00 | +15.0K | 186.4K | +9% | $0 | |
| 2024-06-11 | 2024-06-08 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $6.19 | -2,376 | 171.4K | -1% | -$14.7K | |
| M | 2024-03-04 | 2024-02-29+ | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $3.25 | -4,806 | 174.5K | -3% | -$15.6K |
| 2024-02-27 | 2024-02-23 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $2.74 | -229 | 178.6K | -0.1% | -$627.46 | |
| 2023-11-14 | 2023-11-11 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $2.00 | -413 | 178.8K | -0.2% | -$826 | |
| DM | 2023-06-13 | 2023-06-09 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | A - Grant | $0.00 | +73.8K | 179.2K | +70% | $0 |
| DM | 2023-03-06 | 2023-03-02 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | A - Grant | $0.00 | +18.5K | 105.4K | +21% | $0 |
| 2023-03-02 | 2023-02-28 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $12.38 | -1,005 | 86.9K | -1% | -$12.4K | |
| M | 2023-02-27 | 2023-02-23+ | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $13.99 | -489 | 87.9K | -0.6% | -$6,840 |
| M | 2022-12-13 | 2022-12-09 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | A - Grant | $0.00 | +56.2K | 88.4K | +174% | $0 |
| 2022-11-15 | 2022-11-11 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $15.00 | -416 | 32.2K | -1% | -$6,240 | |
| DM | 2022-03-03 | 2022-03-01 | EBS | Emergent BioSolutions Inc. | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | A - Grant | $0.00 | +25.4K | 14.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations